ADGRL4 and central nervous system cancer: In 2013, another research group led by Towner et al. introduced the idea of “ELTD1 as novel biomarker for glioma” [42], and their studies were later expanded by others, then Xiao and colleagues linked the cardiac hypertrophy to the low ELTD1 expression in mice [21].